Compare WAT & SATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WAT | SATS |
|---|---|---|
| Founded | 1958 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Telecommunications Equipment |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7B | 31.8B |
| IPO Year | 1996 | 2007 |
| Metric | WAT | SATS |
|---|---|---|
| Price | $326.59 | $107.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 5 |
| Target Price | ★ $386.59 | $129.00 |
| AVG Volume (30 Days) | 1.4M | ★ 4.3M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.47 | ★ 92.99 |
| EPS | ★ 10.76 | N/A |
| Revenue | ★ $3,165,286,000.00 | N/A |
| Revenue This Year | $103.90 | N/A |
| Revenue Next Year | $11.12 | N/A |
| P/E Ratio | $30.33 | ★ N/A |
| Revenue Growth | ★ 6.99 | N/A |
| 52 Week Low | $275.05 | $14.90 |
| 52 Week High | $414.15 | $132.25 |
| Indicator | WAT | SATS |
|---|---|---|
| Relative Strength Index (RSI) | 32.38 | 42.59 |
| Support Level | $281.33 | $104.84 |
| Resistance Level | $363.09 | $111.39 |
| Average True Range (ATR) | 12.35 | 4.99 |
| MACD | -1.36 | -1.05 |
| Stochastic Oscillator | 24.32 | 17.80 |
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
Satellite television provides the bulk of EchoStar's revenue. The firm serves about 5 million US satellite customers, about 10% of the traditional television market. It also serves 2 million customers under the Sling brand. EchoStar has also amassed an extensive portfolio of spectrum licenses and is building a nationwide wireless network. It acquired Sprint's prepaid business, serving approximately 7 million customers, primarily under the Boost brand. The firm has agreed to sell a portion of its wireless licenses to AT&T and SpaceX, and will rely heavily on the AT&T network to serve customers. EchoStar's legacy businesses provide satellite telecom services and equipment to businesses and consumers, including about 800,000 internet customers.